Clinical Trials Browser

Phase 1/2 × INDUSTRY × IPI-926 × Clear all

NCT01130142 2017-03-06

A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms